Medpace Holdings, Inc. (MEDP) News
Filter MEDP News Items
MEDP News Results
|Loading, please wait...|
MEDP News Highlights
- 500 - Internal server error
- Over the past 29 days, the trend for MEDP's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
Latest MEDP News From Around the Web
Below are the latest news stories about Medpace Holdings Inc that investors may wish to consider to help them evaluate MEDP as an investment opportunity.
naphtalina/iStock via Getty Images Medpace (MEDP) shed ~5.7% on Wednesday to witness its biggest one-day loss in three months despite posting better-than-expected Q2 financials the previous day. Commenting on the results, Baird says the company’s performance relative to rival contract research organizations has done little to justify its sizable valuation premium....
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Good morning and thank you for joining Medpace's second-quarter 2021 earnings conference call. Also on the call today is our President and CEO, August Troendle; our CFO and COO of laboratory operations, Jesse Geiger; and our executive director of finance, Kevin Brady.
Medpace (MEDP) delivered earnings and revenue surprises of 8.16% and 2.62%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CINCINNATI, July 26, 2021--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced the appointment of Jesse Geiger as president and Kevin Brady as chief financial officer, effective August 1, 2021. August Troendle will continue to serve as Medpace’s chairman and chief executive officer.
CINCINNATI, July 26, 2021--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the second quarter ended June 30, 2021.
No summary available.
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Robert W. Baird Stick to Their Hold Rating for Medpace Holdings
Stock markets run on fear and greed in the short term.